Literature DB >> 31765920

A comprehensive proteomics analysis of JC virus Agnoprotein-interacting proteins: Agnoprotein primarily targets the host proteins with coiled-coil motifs.

A Sami Saribas1, Prasun K Datta1, Mahmut Safak2.   

Abstract

JC virus (JCV) Agnoprotein (Agno) plays critical roles in successful completion of the viral replication cycle. Understanding its regulatory roles requires a complete map of JCV-host protein interactions. Here, we report the first Agno interactome with host cellular targets utilizing "Two-Strep-Tag" affinity purification system coupled with mass spectroscopy (AP/MS). Proteomics data revealed that Agno primarily targets 501 cellular proteins, most of which contain "coiled-coil" motifs. Agno-host interactions occur in several cellular networks including those involved in protein synthesis and degradation; and cellular transport; and in organelles, including mitochondria, nucleus and ER-Golgi network. Among the Agno interactions, Rab11B, Importin and Crm-1 were first validated biochemically and further characterization was done for Crm-1, using a HIV-1 Rev-M10-like Agno mutant (L33D + E34L), revealing the critical roles of L33 and E34 residues in Crm-1 interaction. This comprehensive proteomics data provides new foundations to unravel the critical regulatory roles of Agno during the JCV life cycle.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  BK virus; Coiled-coil; Crm-1; Endosome trafficking; Golgi; Importin; Interactome; JCV; Leucine zipper; Merkel cell carcinoma virus; Mitochondria; Nucleus; Polyomavirus; Progressive multifocal leukoencephalopathy; Rab11B and HIV-1 Rev M10 mutant; SV40; α-helix

Mesh:

Substances:

Year:  2019        PMID: 31765920      PMCID: PMC6957716          DOI: 10.1016/j.virol.2019.10.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  86 in total

1.  JC virus nucleotides 376-396 are critical for VP1 capsid protein expression.

Authors:  Laura C Ellis; Igor J Koralnik
Journal:  J Neurovirol       Date:  2014-08-21       Impact factor: 2.643

2.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

Review 3.  Protein import into the cell nucleus.

Authors:  C Dingwall; R A Laskey
Journal:  Annu Rev Cell Biol       Date:  1986

4.  Recurrent De Novo Mutations Disturbing the GTP/GDP Binding Pocket of RAB11B Cause Intellectual Disability and a Distinctive Brain Phenotype.

Authors:  Ideke J C Lamers; Margot R F Reijnders; Hanka Venselaar; Alison Kraus; Sandra Jansen; Bert B A de Vries; Gunnar Houge; Gyri Aasland Gradek; Jieun Seo; Murim Choi; Jong-Hee Chae; Ineke van der Burgt; Rolph Pfundt; Stef J F Letteboer; Sylvia E C van Beersum; Simone Dusseljee; Han G Brunner; Dan Doherty; Tjitske Kleefstra; Ronald Roepman
Journal:  Am J Hum Genet       Date:  2017-10-26       Impact factor: 11.025

5.  Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle.

Authors:  Ilker K Sariyer; Ilhan Akan; Victoria Palermo; Jennifer Gordon; Kamel Khalili; Mahmut Safak
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Establishment of a line of human fetal glial cells that supports JC virus multiplication.

Authors:  E O Major; A E Miller; P Mourrain; R G Traub; E de Widt; J Sever
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  J Cell Physiol       Date:  2017-08-28       Impact factor: 6.384

8.  Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen.

Authors:  Ilker K Sariyer; Kamel Khalili; Mahmut Safak
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

9.  Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual.

Authors:  R A Du Pasquier; S Corey; D H Margolin; K Williams; L-A Pfister; U De Girolami; J J Mac Key; C Wüthrich; J T Joseph; I J Koralnik
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

10.  BKV agnoprotein interacts with α-soluble N-ethylmaleimide-sensitive fusion attachment protein, and negatively influences transport of VSVG-EGFP.

Authors:  Mona Johannessen; Mari Walquist; Nancy Gerits; Marte Dragset; Anne Spang; Ugo Moens
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

View more
  7 in total

1.  A polyomavirus detected in American black bear (Ursus americanus).

Authors:  Arturo Oliver-Guimerá; Alžběta Hejtmánková; Kenneth Jackson; Patricia A Pesavento
Journal:  Arch Virol       Date:  2021-03-15       Impact factor: 2.574

2.  Human neurotropic polyomavirus, JC virus, agnoprotein targets mitochondrion and modulates its functions.

Authors:  Reshu Saxena; Sami Saribas; Pooja Jadiya; Dhanendra Tomar; Rafal Kaminski; John W Elrod; Mahmut Safak
Journal:  Virology       Date:  2020-11-25       Impact factor: 3.616

3.  A Comprehensive Proteomics Analysis of the JC Virus (JCV) Large and Small Tumor Antigen Interacting Proteins: Large T Primarily Targets the Host Protein Complexes with V-ATPase and Ubiquitin Ligase Activities While Small t Mostly Associates with Those Having Phosphatase and Chromatin-Remodeling Functions.

Authors:  Sami Saribas; Mahmut Safak
Journal:  Viruses       Date:  2020-10-20       Impact factor: 5.048

Review 4.  Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions.

Authors:  Abigail L Atkinson; Walter J Atwood
Journal:  Viruses       Date:  2020-09-01       Impact factor: 5.048

Review 5.  The oncogenic roles of JC polyomavirus in cancer.

Authors:  Hua-Chuan Zheng; Hang Xue; Cong-Yu Zhang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

Review 6.  The Role of the JC Virus in Central Nervous System Tumorigenesis.

Authors:  Nicholas Ahye; Anna Bellizzi; Dana May; Hassen S Wollebo
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

7.  Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.

Authors:  Trinayan Kashyap; Jackelyn Murray; Christopher J Walker; Hua Chang; Sharon Tamir; Bing Hou; Sharon Shacham; Michael G Kauffman; Ralph A Tripp; Yosef Landesman
Journal:  Antiviral Res       Date:  2021-06-19       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.